Icons / Logo / Facebook Created with Sketch. Icons / Logo / Google Created with Sketch. Icons / Logo / ORCID Created with Sketch. Branding/Logomark minus Citation Combined Shape Icon/Bookmark-empty Icon/Copy Icon/Collection Icon/Close Copy 7 no author result Created with Sketch. Icon/Back Created with Sketch. Match!
Andrés Íñiguez-Romo
University Hospital Complex Of Vigo
43Publications
5H-index
156Citations
Publications 43
Newest
Published on May 20, 2019in American Journal of Cardiovascular Drugs 2.58
Ovidio De Fillippo1
Estimated H-index: 1
(UNITO: University of Turin),
Martina Cortese1
Estimated H-index: 1
(UNITO: University of Turin)
+ 35 AuthorsLazar Velicki7
Estimated H-index: 7
(University of Novi Sad)
Published on Apr 27, 2019in American Journal of Cardiovascular Drugs 2.58
Ovidio De Filippo2
Estimated H-index: 2
(UNITO: University of Turin),
Ovidio De Fillippo1
Estimated H-index: 1
(UNITO: University of Turin)
+ 35 AuthorsChristian Templin27
Estimated H-index: 27
(UZH: University of Zurich)
Background Limited data are available concerning differences in clinical outcomes for real-life patients treated with ticagrelor versus prasugrel after percutaneous coronary intervention (PCI).
Published on May 1, 2019
Isabel Muñoz Pousa2
Estimated H-index: 2
,
Emad Abu Assi16
Estimated H-index: 16
+ 15 AuthorsRafael Cobas Paz2
Estimated H-index: 2
Abstract Introduction and objectives The concurrence of cancer and ischemic heart disease is a controversial issue, given the confluence of risk factors for both diseases. The aim of this study is to analyze the incidence, predictors, and prognosis of new-onset cancer after an acute coronary syndrome (ACS). Methods Retrospective multicenter registry that includes 3867 consecutive patients discharged for ACS without a known history of cancer, from 2011 to 2015. The association between clinical va...
Published on Jun 1, 2019in Revista Espanola De Cardiologia 5.13
José Ramón López Mínguez16
Estimated H-index: 16
,
Juan Manuel Nogales-Asensio10
Estimated H-index: 10
+ 11 AuthorsVictoria Martin-Yuste13
Estimated H-index: 13
Abstract Introduction and objectives Many patients with nonvalvular atrial fibrillation are still left without protection due to a contraindication for anticoagulants. This study aimed to establish the occurrence of stroke and major bleeding events in patients with nonvalvular atrial fibrillation and left atrial appendage closure with long-term follow-up and to explore the factors associated with higher long-term mortality. Methods Analysis of a multicenter single cohort prospectively recruited ...
Published on Jun 1, 2019in Revista Espanola De Cardiologia 5.13
José Ramón López Mínguez16
Estimated H-index: 16
,
Juan Manuel Nogales-Asensio10
Estimated H-index: 10
+ 11 AuthorsVictoria Martin-Yuste13
Estimated H-index: 13
Resumen Introduccion y objetivos Muchos pacientes con fibrilacion auricular no valvular tienen contraindicados los anticoagulantes orales. El objetivo es estimar la incidencia de eventos tromboembolicos y hemorragicos en pacientes con fibrilacion auricular no valvular y cierre de la orejuela izquierda con seguimiento a largo plazo, y determinar los factores asociados con mayor mortalidad a largo plazo. Metodos Cohorte prospectiva de pacientes reclutados desde 2009 a 2015. Se compararon los event...
Published on May 1, 2019in Revista Espanola De Cardiologia 5.13
Sergio Raposeiras-Roubín13
Estimated H-index: 13
,
Emad Abu Assi16
Estimated H-index: 16
+ 46 AuthorsRafael Cobas-Paz1
Estimated H-index: 1
Abstract Introduction and objectives For patients with acute coronary syndrome (ACS) treated with percutaneous coronary intervention (PCI), it is unclear whether angiotensin-converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARB) are associated with reduced mortality, particularly with preserved left ventricular ejection fraction (LVEF). The goal of this study was to determine the association between ACEI/ARB and mortality in ACS patients undergoing PCI, with and without reduc...
Published on May 1, 2019in Revista Espanola De Cardiologia 5.13
Andrés Íñiguez-Romo5
Estimated H-index: 5
,
José Antonio Baz14
Estimated H-index: 14
+ 2 AuthorsEmad Abu Assi16
Estimated H-index: 16
Sergio Raposeiras-Roubín13
Estimated H-index: 13
,
Emad Abu Assi16
Estimated H-index: 16
+ 46 AuthorsWouter J. Kikkert12
Estimated H-index: 12
(UvA: University of Amsterdam)
Background:The rate of intracranial haemorrhage after an acute coronary syndrome has been studied in detail in the era of thrombolysis; however, in the contemporary era of percutaneous coronary intervention, most of the data have been derived from clinical trials. With this background, we aim to analyse the incidence, timing, predictors and prognostic impact of post-discharge intracranial haemorrhage in patients with acute coronary syndrome undergoing percutaneous coronary intervention.Methods:W...
Published on Apr 1, 2019in Revista Espanola De Cardiologia 5.13
Sergio Raposeiras-Roubín13
Estimated H-index: 13
,
Emad Abu Assi16
Estimated H-index: 16
+ 35 AuthorsIoanna Xanthopoulou20
Estimated H-index: 20
Resumen Introduccion y objetivos Hay muy poca evidencia sobre las tasas de trombosis del stent (TS) en pacientes que reciben tratamiento antiagregante plaquetario doble (TAPD) con ticagrelor o prasugrel. El objetivo de este estudio es analizar la incidencia y predictores de la TS tras un sindrome coronario agudo en pacientes que reciben TAPD con ticagrelor frente a prasugrel. Metodos Se utilizaron datos del registro RENAMI (REgistry of New Antiplatelet therapy in patients with acute Myocardial I...
Published on Apr 1, 2019in Revista Espanola De Cardiologia 5.13
Sergio Raposeiras-Roubín13
Estimated H-index: 13
,
Emad Abu Assi16
Estimated H-index: 16
+ 35 AuthorsIoanna Xanthopoulou20
Estimated H-index: 20
Abstract Introduction and objectives There is little evidence on rates of stent thrombosis (ST) in patients receiving dual antiplatelet therapy (DAPT) with ticagrelor or prasugrel. The aim of this study was to analyze the incidence and predictors of ST after an acute coronary syndrome among patients receiving DAPT with ticagrelor vs prasugrel. Methods We used data from the RENAMI registry (REgistry of New Antiplatelet therapy in patients with acute Myocardial Infarction), analyzing a total of 41...
12345